Cann Group Ltd CAN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.06
- Day Range
- A$0.06–0.06
- 52-Week Range
- A$0.06–0.19
- Bid/Ask
- A$0.00 / A$0.00
- Market Cap
- A$27.14 Mil
- Volume/Avg
- 636,367 / 355,339
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.53
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the company; the development and manufacture (via third party arrangements) of finished product formulations; and the pursuit and execution of various supply and offtake agreements with third parties.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://www.canngrouplimited.com
Valuation
|
Metric
|
CAN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.53 |
Price/Sales | 1.53 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CAN
|
|---|---|
Quick Ratio | 0.07 |
Current Ratio | 0.26 |
Interest Coverage | −6.23 |
Quick Ratio
CAN
Profitability
|
Metric
|
CAN
|
|---|---|
Return on Assets (Normalized) | −23.26% |
Return on Equity (Normalized) | −50.01% |
Return on Invested Capital (Normalized) | −21.75% |
Return on Assets
CAN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Hwkhzmfv | Cdnkt | $71.2 Bil | |
ZTS
| Zoetis Inc Class A | Knvxrdlz | Hxyg | $68.3 Bil | |
HLN
| Haleon PLC ADR | Hmddzrsbt | Tqczd | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Gslfyrtn | Cmfh | $14.5 Bil | |
VTRS
| Viatris Inc | Wnjhlvv | Nzrwj | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hfgjwcn | Vwpwk | $11.9 Bil | |
CTLT
| Catalent Inc | Gnnkmglc | Hjkpvpx | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Nbphkckw | Jrjm | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Zkvbxxp | Fxsr | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Mhxqmrxdb | Qcfjs | $3.5 Bil |